cytochrome P450, family 2, subfamily C, polypeptide 9 |
CLOSANTEL |
CYP450-2C9 Inhibition |
89% |
2uM |
NoneNone |
View
|
Cytochrom P450-2C19 monooxygenase |
MOSAPRIDE |
CYP450-2C19 Inhibition |
89% |
1uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
DIPHENIDOL |
Muscarinic M5 |
89% |
1.191uM |
.855uM |
View
|
thromboxane A synthase 1 |
BITHIONOL |
Thromboxane Synthetase |
89% |
1.84uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
BITHIONOL |
Thromboxane Synthetase |
89% |
1.84uM |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
AMITRAZ |
Adrenergic alpha2A |
89% |
.9269uM |
.3476uM |
View
|
FMS-like tyrosine kinase 1 |
DIGITONIN |
Vascular Endothelinal Growth Factor (VEGF) |
89% |
3.859uM |
1.001uM |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
DIGITONIN |
Vascular Endothelinal Growth Factor (VEGF) |
89% |
3.859uM |
1.001uM |
View
|
adrenergic receptor, alpha 2a |
DIHYDROERGOCRISTINE MESYLATE |
Imidazoline I2, Central |
89% |
.005428uM |
.003619uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
DIHYDROERGOCRISTINE MESYLATE |
Imidazoline I2, Central |
89% |
.005428uM |
.003619uM |
View
|
adrenergic receptor, alpha 1b |
EPINEPHRINE |
Adrenergic alpha1B |
89% |
1.766uM |
.977uM |
View
|
mu-opioid receptor MOR |
NELFINAVIR |
Opiate mu |
89% |
14.432uM |
5.859uM |
View
|
adrenergic receptor, alpha 1b |
CINNARIZINE |
Adrenergic alpha1B |
89% |
.906uM |
.502uM |
View
|
5-hydroxytryptamine receptor 6 |
SULFADIMETHOXINE |
Serotonin 5-HT6 |
87% |
1.339uM |
.622uM |
View
|
Cytochrom P450-1A2 monooxygenase |
PROCHLORPERAZINE |
CYP450-1A2 Inhibition |
87% |
2uM |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
SAQUINAVIR |
Serotonin 5-HT1A |
87% |
4.273uM |
2.442uM |
View
|
adrenergic receptor, alpha 2a |
SELEGILINE |
Imidazoline I2, Central |
87% |
1.614uM |
1.076uM |
View
|
adrenergic receptor, alpha 2c (Non-specific probe) |
SELEGILINE |
Imidazoline I2, Central |
87% |
1.614uM |
1.076uM |
View
|
adrenergic receptor, beta 3 |
OXICONAZOLE |
Adrenergic beta3 |
87% |
4.7449uM |
3.5587uM |
View
|
dopamine receptor D1A |
EBASTINE |
Dopamine D1 |
87% |
1.1929uM |
.5965uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
MONTELUKAST |
Adrenergic, Norepinephrine Transporter |
87% |
2.689uM |
2.667uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
RESVERATROL |
Adrenergic, Norepinephrine Transporter |
87% |
2.312uM |
2.293uM |
View
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CETYLPYRIDINIUM BROMIDE |
Adrenergic, Norepinephrine Transporter |
87% |
2.653uM |
2.631uM |
View
|
opioid receptor, sigma 1 |
RALOXIFENE |
Sigma1 |
87% |
.681uM |
.286uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1B |
RALOXIFENE |
Serotonin 5-HT1B |
87% |
1.861uM |
.846uM |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
SIBUTRAMINE |
Dopamine Transporter |
87% |
.632uM |
.502uM |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
STANOZOLOL |
CYP450-2C9 Inhibition |
87% |
1.1276uM |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
STANOZOLOL |
CYP450-2C9 Inhibition |
87% |
1.1276uM |
NoneNone |
View
|
adrenergic receptor, alpha 2b |
BENZETHONIUM CHLORIDE |
Adrenergic alpha2B |
87% |
.643uM |
.294uM |
View
|
cholinergic receptor, muscarinic 5 |
BENZETHONIUM CHLORIDE |
Muscarinic M5 |
87% |
.134uM |
.096uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
ASTEMIZOLE |
Serotonin 5-HT1A |
87% |
.767uM |
.438uM |
View
|
nuclear receptor subfamily 3, group C, member 1 |
SPIRONOLACTONE |
Glucocorticoid |
87% |
1.9025uM |
.8648uM |
View
|
dopamine receptor D3 |
BAY 11-7085 |
Dopamine D3 |
87% |
3.46uM |
1.175uM |
View
|
5-hydroxytryptamine receptor 6 |
ASTEMIZOLE |
Serotonin 5-HT6 |
87% |
3.266uM |
1.516uM |
View
|
Sigma-2 Receptor |
CLOMIPHENE |
Sigma2 |
87% |
.049uM |
.03uM |
View
|
mitogen activated protein kinase 1 |
ANTIMYCIN A |
Protein Serine/Threonine Kinase, ERK2 |
87% |
2.116uM |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
ANTIMYCIN A |
Protein Serine/Threonine Kinase, ERK2 |
87% |
2.116uM |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
NELFINAVIR |
Calcium Channel Type L, Dihydropyridine |
87% |
9.84uM |
6.324uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
NELFINAVIR |
Calcium Channel Type L, Dihydropyridine |
87% |
9.84uM |
6.324uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
NELFINAVIR |
Calcium Channel Type L, Dihydropyridine |
87% |
9.84uM |
6.324uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
NELFINAVIR |
Calcium Channel Type L, Dihydropyridine |
87% |
9.84uM |
6.324uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
NELFINAVIR |
Calcium Channel Type L, Dihydropyridine |
87% |
9.84uM |
6.324uM |
View
|
Sigma-2 Receptor |
TERBINAFINE |
Sigma2 |
87% |
.0354uM |
.0218uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
CINNARIZINE |
Adrenergic alpha1D |
87% |
1.167uM |
.573uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
U-78517F |
Calcium Channel Type L, Dihydropyridine |
86% |
1.659uM |
1.066uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
U-78517F |
Calcium Channel Type L, Dihydropyridine |
86% |
1.659uM |
1.066uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
U-78517F |
Calcium Channel Type L, Dihydropyridine |
86% |
1.659uM |
1.066uM |
View
|
mitogen activated protein kinase 14 |
U-78517F |
Protein Serine/Threonine Kinase, p38alpha |
86% |
5.596uM |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
U-78517F |
Protein Serine/Threonine Kinase, p38alpha |
86% |
5.596uM |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
AMOXAPINE |
Muscarinic M3 |
86% |
1.781uM |
.378uM |
View
|
melanocortin 4 receptor |
AMIODARONE |
Melanocortin MC4 |
86% |
13.755uM |
13.226uM |
View
|
cholinergic receptor, muscarinic 1 |
AMIODARONE |
Muscarinic M1 |
86% |
2.613uM |
.629uM |
View
|
epidermal growth factor receptor |
TAMOXIFEN |
Protein Tyrosine Kinase, EGF Receptor |
86% |
3.553uM |
NoneNone |
View
|
dopamine receptor D3 |
DICYCLOMINE |
Dopamine D3 |
86% |
1.21uM |
.411uM |
View
|
adrenergic receptor, alpha 1d (Non-specific probe) |
CISAPRIDE |
Adrenergic alpha1D |
86% |
.189uM |
.093uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOMIPRAMINE |
Calcium Channel Type L, Phenylalkylamine |
86% |
.506uM |
.492uM |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
CARVEDILOL |
Serotonin 5-HT4 |
86% |
1.088uM |
.181uM |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
CARVEDILOL |
Serotonin 5-HT4 |
86% |
1.088uM |
.181uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
FLUNARIZINE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.012uM |
.65uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
FLUNARIZINE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.012uM |
.65uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
FLUNARIZINE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.012uM |
.65uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
FLUNARIZINE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.012uM |
.65uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
FLUNARIZINE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.012uM |
.65uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
FLUNARIZINE |
Calcium Channel Type L, Dihydropyridine |
90% |
1.012uM |
.65uM |
View
|
Cytochrom P450-2D6 monooxygenase |
TICLOPIDINE |
CYP450-2D6 Inhibition |
90% |
6.2928uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
YOHIMBINE |
CYP450-2D6 Inhibition |
90% |
2.0317uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
PHENTOLAMINE |
CYP450-2D6 Inhibition |
90% |
10uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
PYRILAMINE |
CYP450-2D6 Inhibition |
90% |
.3uM |
NoneNone |
View
|
Cytochrom P450-2D6 monooxygenase |
CISAPRIDE |
CYP450-2D6 Inhibition |
90% |
.07uM |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
FELODIPINE |
CYP450-2C9 Inhibition |
90% |
4.5795uM |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
FELODIPINE |
CYP450-2C9 Inhibition |
90% |
4.5795uM |
NoneNone |
View
|
mitogen activated protein kinase 1 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Protein Serine/Threonine Kinase, ERK2 |
90% |
.886uM |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
3,3',4',5-TETRACHLOROSALICYLANILIDE |
Protein Serine/Threonine Kinase, ERK2 |
90% |
.886uM |
NoneNone |
View
|
adenosine A2a receptor |
BITHIONOL |
Adenosine A2A |
90% |
1.167uM |
.655uM |
View
|
A3 adenosine receptor |
CLOSANTEL |
Adenosine A3 |
90% |
.096uM |
.054uM |
View
|
acetylcholinesterase (YT blood group) |
CLOSANTEL |
Acetylcholinesterase |
90% |
2.951uM |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CLOSANTEL |
Acetylcholinesterase |
90% |
2.951uM |
NoneNone |
View
|
acetylcholinesterase |
CLOSANTEL |
Acetylcholinesterase |
90% |
2.951uM |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
GRAMICIDIN |
Protein Tyrosine Kinase, Fyn |
90% |
3.331uM |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
CINNARIZINE |
Adrenergic alpha2A |
90% |
.444uM |
.167uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
BUSPIRONE |
Serotonin 5-HT2B |
90% |
.75uM |
.477uM |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
QUETIAPINE |
Serotonin 5-HT1A |
90% |
1.4264uM |
.8151uM |
View
|
mu-opioid receptor MOR |
DIHYDROERGOCRISTINE MESYLATE |
Opiate mu |
90% |
.85uM |
.345uM |
View
|
5-hydroxytryptamine (serotonin) receptor 2A |
PYRILAMINE |
Serotonin 5-HT2A |
90% |
.997uM |
.285uM |
View
|
dopamine receptor 2 |
PROMAZINE |
Dopamine D2L |
90% |
.505uM |
.168uM |
View
|
adrenergic receptor, alpha 2a |
TERCONAZOLE |
Imidazoline I2, Central |
90% |
2.226uM |
1.484uM |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
CHLORDIAZEPOXIDE |
GABAA, Benzodiazepine, Central |
89% |
1.429uM |
1.164uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
PROMETHAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.866uM |
.842uM |
View
|
A3 adenosine receptor |
LACIDIPINE |
Adenosine A3 |
89% |
4.036uM |
2.281uM |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
HALOPERIDOL |
Calcium Channel Type L, Phenylalkylamine |
88% |
.552uM |
.536uM |
View
|
Protein-tyrosine kinase, Fyn |
GENTIAN VIOLET |
Protein Tyrosine Kinase, Fyn |
88% |
2.148uM |
NoneNone |
View
|
opioid receptor, sigma 1 |
MEPAZINE |
Sigma1 |
88% |
.18uM |
.076uM |
View
|
dopamine receptor D3 |
LOPERAMIDE |
Dopamine D3 |
88% |
1.337uM |
.454uM |
View
|
opioid receptor, delta 1 |
LOPERAMIDE |
Opiate delta |
88% |
.896uM |
.316uM |
View
|
dopamine receptor D1A |
METHYSERGIDE |
Dopamine D1 |
88% |
.943uM |
.472uM |
View
|
arachidonate 15-lipoxygenase, second type |
MITOXANTRONE |
Lipoxygenase 15-LO |
88% |
1.7853uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
MITOXANTRONE |
Lipoxygenase 15-LO |
88% |
1.7853uM |
NoneNone |
View
|
arachidonate 15-lipoxygenase |
MITOXANTRONE |
Lipoxygenase 15-LO |
88% |
1.7853uM |
NoneNone |
View
|
epidermal growth factor receptor |
L-744832 |
Protein Tyrosine Kinase, EGF Receptor |
88% |
3.216uM |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
IRINOTECAN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
88% |
6.06uM |
NoneNone |
View
|
5-hydroxytryptamine receptor 6 |
KETOTIFEN |
Serotonin 5-HT6 |
88% |
1.141uM |
.53uM |
View
|
adrenergic receptor, alpha 2a |
KETOTIFEN |
Adrenergic alpha2A |
88% |
2.187uM |
.82uM |
View
|
thromboxane A synthase 1 |
RITONAVIR |
Thromboxane Synthetase |
88% |
.076uM |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
RITONAVIR |
Thromboxane Synthetase |
88% |
.076uM |
NoneNone |
View
|
adrenergic receptor, beta 3 |
MONTELUKAST |
Adrenergic beta3 |
88% |
4.3uM |
3.2uM |
View
|
phosphodiesterase 4A, cAMP specific |
PAPAVERINE |
Phosphodiesterase PDE4 |
88% |
.817uM |
NoneNone |
View
|
phosphodiesterase 4C, cAMP-specific |
PAPAVERINE |
Phosphodiesterase PDE4 |
88% |
.817uM |
NoneNone |
View
|
phosphodiesterase 4D |
PAPAVERINE |
Phosphodiesterase PDE4 |
88% |
.817uM |
NoneNone |
View
|
phosphodiesterase 4B, cAMP specific |
PAPAVERINE |
Phosphodiesterase PDE4 |
88% |
.817uM |
NoneNone |
View
|
phosphodiesterase 3B |
PAPAVERINE |
Phosphodiesterase PDE3 |
88% |
.665uM |
NoneNone |
View
|
phosphodiesterase 3A |
PAPAVERINE |
Phosphodiesterase PDE3 |
88% |
.665uM |
NoneNone |
View
|